G.R. No. 218652 - Villanueva vs. People

Case Summary (G.R. No. 218652)

Petitioner

Rodrigo D. Villanueva is a private person acting as president/general manager and principal owner (99% capital stock) of AM‑Europharma Corporation and as sole proprietor of Mallix Drug Center. He participated in the January 2001 municipal procurement and was charged as a conspirator with municipal officials for acts giving unwarranted benefit to his businesses.

Respondent

People of the Philippines prosecuted the case through investigations by the Office of the Ombudsman and trial and conviction by the Sandiganbayan. The COA and provincial auditor performed audits that uncovered irregularities; the DOH and BFAD provided accreditation and laboratory testing records relevant to bidder qualification and product quality.

Key Dates and Events

December 19, 2000: MOA executed between Municipality of Janiuay (via Mayor Locsin as LMP‑Iloilo President) and DOH to implement a rescue/ emergency medicines program; DOH released P15,000,000.
January 12, 2001: Scheduled bidding postponed due to absence of provincial auditor.
January 15, 2001: Bidding conducted; awards recommended and approved to AM‑Europharma (P13,191,223.00) and Mallix Drug (P1,744,926.00) despite absence of provincial auditor.
January 16–17, 2001: Purchase orders and certificates of acceptance issued; medicines delivered and inspected; municipality issued checks and suppliers issued official receipts; Europharma’s DOH accreditation was issued only on January 17, 2001 (after the bidding).
Post‑audit 2001: Provincial auditor issued notices of suspension/disallowance and uncovered that Europharma and Mallix were owned/controlled by Villanueva and that Europharma’s accreditation was suspended at bidding time. BFAD reported a failed test for cotrimoxazole (P240,000.00), with replacement delivered October 16, 2001.
Sandiganbayan decision: February 23, 2015 — conviction under RA 3019 §3(e).
Sandiganbayan resolution denying reconsideration: June 8, 2015.
Supreme Court disposition referenced in prompt: petition denied and Sandiganbayan decision affirmed.

Applicable Law and Legal Authorities

1987 Constitution (basis for the decision; anti‑graft jurisdiction considerations).
Republic Act No. 3019 (Anti‑Graft and Corrupt Practices Act), Section 3(e) — criminalizes giving unwarranted benefits, advantage or preference through manifest partiality, evident bad faith or gross inexcusable negligence.
Rule 110, Section 6 of the Rules of Court — sufficiency of information (requires naming of accused, designation of offense, acts or omissions complained of, offended party, approximate date and place).
Commission on Audit Circular No. 92‑386 (as cited regarding when public bidding is deemed a failure).
Local Government Code, Section 368 — emergency purchase provisions (conditions required to dispense with public bidding).
Controlling jurisprudence cited in the decision: Cabrera v. People; Pacifico C. Velasco v. Sandiganbayan; Alvarez v. People; People v. Go; Dela Cruz v. People; and other cited authorities concerning conspiracy, corporate veil piercing, and private‑person liability under RA 3019.

Factual Summary of Procurement and Audits

The municipality, acting under an MOA with DOH to implement an emergency medicines program funded with P15,000,000, published invitations to bid. Three entities were alleged respondents: AM‑Europharma, Mallix Drug, and Phil. Pharmawealth, Inc. Bidding scheduled for January 12, 2001 was postponed for lack of a provincial auditor; on January 15, 2001 the Committee on Awards proceeded to open bids despite the auditor’s continued absence and recommended awards to Europharma and Mallix. Mayor Locsin approved the awards; purchase orders and certificates of acceptance were dated January 16, 2001 and medicines were delivered and received that day. Checks were issued January 17, 2001 and receipts were issued to petitioner’s companies. BFAD testing later found one drug batch non‑compliant; replacement was eventually delivered. The provincial auditor’s post‑audit revealed that Europharma’s DOH accreditation was suspended at the time of bidding and that both suppliers were owned or controlled by Villanueva, prompting notices of suspension/disallowance and referral to the Ombudsman.

Criminal Information and Plea

The Amended Information charged Villanueva and municipal officers with violating Section 3(e) of RA 3019 by conniving to award contracts to Europharma and Mallix despite Europharma’s suspended DOH accreditation and common ownership/control, giving the petitioner unwarranted benefits and preference to the prejudice of other companies and public service. Villanueva pleaded not guilty and proceeded to trial.

Sandiganbayan Findings and Sentence

The Sandiganbayan found all accused guilty beyond reasonable doubt of violating RA 3019 §3(e), concluding they acted with manifest partiality and evident bad faith in awarding contracts to petitioner’s entities. The court relied on several indicia: signatures in the Minutes of Meeting, undue haste in delivery and payment, lack of a 10% performance bond, irregularities in accreditation, and the overlap/relationship between the two winning bidders. Villanueva was held to have conspired with public officials based on his conduct before, during, and after bidding. Sentence imposed: indeterminate penalty of six years and one month to ten years, perpetual disqualification from public office, and proportionate costs; no civil liability was imposed due to failure of the prosecution to prove damage/amount of injury.

Issues Raised in the Petition for Review

Villanueva contested: (1) conviction for matters not specified in the Amended Information; (2) reliance on COA Circular No. 92‑386 as penal law; (3) the claim that procurement was emergency purchase and procurement steps were proper; (4) non‑application of LGC §368 on emergency purchases; (5) failure to recognize LMP’s separate personality and that municipal officers acted in their LMP capacities; (6) acceptance of Pharmawealth’s denial; (7) assertion that Europharma’s LTO renewal was pending and it retained qualifications; (8) insistence that DOH accreditation was not a legal requirement for local government medicines procurement; (9) objection to piercing corporate veil and treating two bidders as one; and (10) challenge to conspiracy finding as based on circumstantial evidence subject to exculpatory equipoise.

Supreme Court’s Analytical Framework and Jurisdictional Approach

The Supreme Court reaffirmed its limited role in Rule 45 petitions to address questions of law, not to re‑weigh factual findings of the Sandiganbayan, which is the special court for graft cases. The Court recognized exceptions permitting factual review only where findings are speculative, the inference is manifestly mistaken, there is grave abuse of discretion, misapprehension of facts, or findings premised on absence of evidence contradicted by the record. The petition raised predominantly factual challenges; thus the Court confined review to legal questions central to whether Section 3(e) of RA 3019 was properly applied.

Legal Elements of Section 3(e) and Sufficiency of the Information

The Court reiterated the elements of RA 3019 §3(e): (a) accused is a public officer discharging official/administrative/judicial functions (private persons may be liable as conspirators); (b) action marked by manifest partiality, evident bad faith, or gross inexcusable negligence; and (c) action caused undue injury to any party or conferred unwarranted benefits, advantage or preference — the disjunctive means proof of undue injury is not required if unwarranted benefit is shown. Under Rule 110 §6, the Amended Information was sufficient because it named the accused, designated the offense, alleged the acts/omissions (connivance, award despite suspended accreditation and common ownership), identified the offended party, and gave approximate date and place.

Court’s Rationale on Key Legal Issues

Vagueness and notice: By pleading and proceeding to trial under the Amended Information, Villanueva was estopped from later claiming vagueness or deprivation of notice; the defense itself was mounted and tested at trial.
COA Circular reliance: The Court accepted the Sandiganbayan’s citation of COA Circular No. 92‑386 to establish standards for what constitutes a failed bidding and used noncompliance with COA standards as evidence of manifest partiality and unwarranted preference, not as a separate penal statute.
Emergency purchase claim: The Court rejected petitioner’s contention that the procurement was an emergency purchase under LGC §368 because the statutory requisites for emergency procurement were not present and the municipality had issued invitations to bid, undermining the claim that competitive bidding was dispensed with.
Damage vs. unwarranted benefit: The Court reaffirmed precedent (Cabrera and others) that Section 3(e) penaliz

Case Syllabus (G.R. No. 218652)

Nature of the Case and Procedural Posture

Petition for review on certiorari under Rule 45 of the Rules of Court filed by petitioner Rodrigo Deriquito Villanueva assailing the Sandiganbayan Decision dated February 23, 2015 and Resolution dated June 8, 2015 in Crim. Case No. SB-08-CRM-0381.
The Sandiganbayan convicted petitioner and co-accused public officers of violating Section 3(e) of Republic Act No. 3019 (Anti-Graft and Corrupt Practices Act).
Petitioner pleaded not guilty at trial and subsequently filed the present petition raising multiple assignments of error; the Supreme Court denied the petition and affirmed the Sandiganbayan judgment on February 23, 2022 (G.R. No. 218652).
The Supreme Court emphasized its limited appellate jurisdiction under Rule 45 to questions of law and reiterated that it is not a trier of facts; factual findings of the Sandiganbayan are generally conclusive except under specific recognized exceptions.

Accusatory Allegations and Amended Information

The Amended Information charged that on or about January 15, 2001, and for some time prior or subsequent thereto, municipal officials of Janiuay, Iloilo (Mayor and members of the Committee on Awards) connived with Rodrigo S. Villanueva, President and General Manager of AM-Europharma Corporation and sole proprietor of Mallix Drug Center, to willfully, unlawfully and criminally award and buy medicines totaling P13,191,223.00 from AM-Europharma and P1,744,926.00 from Mallix Drug Center.
The Amended Information alleged that at the time of bidding AM-Europharma’s accreditation by the Department of Health (DOH) was suspended and that both Europharma and Mallix were owned and controlled by petitioner, yet they were allowed to participate and win, giving petitioner unwarranted benefit, advantage or preference, to the detriment of other companies and public service.
Petitioner was charged with violating Section 3(e) of RA 3019 and later entered a plea and proceeded to trial under the Amended Information.

Factual Background — MOA, Funding, and Procurement Process

On December 19, 2000 the Municipality of Janiuay, through Mayor Franklin A. Locsin as President of the League of Municipalities of the Philippines (LMP), Iloilo Chapter, executed a Memorandum of Agreement (MOA) with DOH-CHD Western Visayas to implement the Rescue and Emergency Disaster Program for purchasing medicines and equipment for distribution to municipalities in Iloilo.
DOH released P15,000,000.00 to the municipal government of Janiuay to implement the program pursuant to the MOA and Sangguniang Bayan Resolution No. 318-2000.
Invitations to Bid were published for a bidding scheduled January 12, 2001 (later postponed to January 15, 2001 due to the provincial auditor’s absence). Respondents alleged bidders were AM-Europharma Corporation, Mallix Drug Center, and Phil. Pharmawealth, Inc.

Bidding, Award, Delivery and Payment

On January 15, 2001, the Committee on Awards (Municipal Accountant Carlos C. Moreno, Municipal Budget Officer Ramon T. Tirador, Municipal Treasurer Luzviminda P. Figueroa, and Mayor Locsin’s representative Ricardo S. Minurtio) proceeded with bid opening despite the provincial auditor’s absence and recommended award to Europharma (P13,191,223.00) and Mallix Drug (P1,744,926.00).
Mayor Locsin approved the awards; purchase orders and certificates of acceptance dated January 16, 2001 were issued; medicines were delivered and received by Mayor Locsin on January 16, 2001 and inspected by Supply Officer Gabriel M. Billena.
The municipality issued checks on January 17, 2001 for payments to Europharma and Mallix Drug, and official receipts were issued to petitioner’s companies. Payment was promptly processed and checks were encashed by the companies.

Post-Delivery Tests, Replacement and Distribution

The Bureau of Food and Drugs (BFAD) conducted analysis on delivered medicines; the drug cotrimoxazole valued at P240,000.00 failed BFAD testing according to the Result of Analysis.
Mallix Drug delivered replacement drugs on October 16, 2001 which were found compliant by BFAD standards.
The medicines were distributed to beneficiary municipalities that were members of the LMP-Iloilo Chapter.

Post-Audit Findings, Notices and Ombudsman Referral

During the provincial audit for calendar year 2001 the provincial auditor discovered that Europharma and Mallix Drug were owned by petitioner and that Europharma’s accreditation was suspended at the time of bidding.
The provincial auditor issued a Notice of Suspension and Notice of Disallowance directing Mayor Locsin and Treasurer Figueroa to justify: failure to notify the Office of the Provincial Auditor of the bidding; omission to require a performance bond; reasons Europharma and Mallix Drug were allowed to bid despite petitioner’s ownership; and submission of list of recipient municipalities with Requisition and Issue Vouchers.
Pharmawealth’s president publicly disclaimed Pharmawealth’s participation in the bidding, and sent a letter to the Commission on Audit which led to the discovery that Europharma was 99% owned by petitioner.
The irregularities prompted referral to the Office of the Ombudsman-Visayas which found probable cause to indict the municipal officers and petitioner for violation of Section 3(e) of RA 3019.

Sandiganbayan’s Findings and Criminal Conviction

The Sandiganbayan found all accused guilty beyond reasonable doubt of violating Section 3(e) of RA 3019 for connivance in awarding contracts to petitioner’s business entities with deliberate intent, manifest partiality and evident bad faith.
The court relied on evidence such as committee members’ signatures on minutes, undue haste in delivery and payment, absence of the required 10% performance bond, and irregularities in accreditation and qualification of the bidders to establish manifest partiality and evident bad faith.
The Sandiganbayan concluded petitioner conspired with public officers based on his conduct before, during and after bidding and his companies’ participation and receipt of payments.
Sentence imposed: indeterminate penalty of six years and one month (minimum) to ten years (maximum); perpetual disqualification from public office; proportionate payment of costs; no civil liabili